➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Medtronic
Boehringer Ingelheim
Baxter

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 9,016,221

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,016,221
Title:Surface topographies for non-toxic bioadhesion control
Abstract: Disclosed herein is an article that includes a first plurality of spaced features. The spaced features are arranged in a plurality of groupings; the groupings of features include repeat units; the spaced features within a grouping are spaced apart at an average distance of about 1 nanometer to about 500 micrometers; each feature having a surface that is substantially parallel to a surface on a neighboring feature; each feature being separated from its neighboring feature; the groupings of features being arranged with respect to one another so as to define a tortuous pathway. The plurality of spaced features provide the article with an engineered roughness index of about 5 to about 20.
Inventor(s): Brennan; Anthony B. (Gainesville, FL), Long; Christopher James (Titusville, FL), Bagan; Joseph W. (Greenwood Village, CO), Schumacher; James Frederick (Cumming, GA), Spiecker; Mark M. (Denver, CO)
Assignee: University of Florida Research Foundation, Inc. (Gainesville, FL)
Application Number:12/550,870
Patent Claims:see list of patent claims

Details for Patent 9,016,221

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Abbvie SURVANTA beractant SUSPENSION;INTRATRACHEAL 020032 001 1992-08-17   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 RX Orphan search
Abbvie Inc. SURVANTA beractant SUSPENSION 020032 1 1991-07-01   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 001 1978-01-16   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 002 1978-01-16   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 003 1978-01-16   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 DISCN search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial University of Florida Research Foundation, Inc. (Gainesville, FL) 2024-02-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Express Scripts
Harvard Business School
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.